Pharmafile.com’s weekly COVID-19 news round-up
May 20, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Trump, coronavirus
Trump continues to play a key role in the unfolding COVID-19 pandemic, with the US currently coping with the largest …
MIT-developed algorithm seeks to accelerate drug approvals during COVID-19 pandemic
May 20, 2020Research and Development, Sales and Marketing COVID-19, MIT, coronavirus, regulatory
A study emerging from the Massachusetts Institute of Technology (MIT) and published in the Harvard Data Science Review has detailed strategies …
New research outlines guidelines for the ethical use of AI in healthcare
May 20, 2020Research and Development AI, coronavirus
A new study published in The Lancet has called on the global health community to establish guidelines to develop and …
Nanotechnology could be used to assess mortality risk in COVID-19 patients
May 20, 2020Research and Development COVID-19, coronavirus, nanotechnology
Doctors could use nanotechnology to assess the morality risk from COVID-19, according to research from Michigan State University. Morteza Mahmoudi, …
Type 1 diabetics more likely to die from COVID-19 than type 2, according to the NHS
May 20, 2020Research and Development COVID-19, Diabetics, coronavirus, diabetes
People suffering type 1 diabetes are far more likely to die of coronavirus than those with type 2, according to …
Interim data for Moderna’s COVID-19 vaccine shows glimmers of hope
May 19, 2020Manufacturing and Production, Research and Development COVID-19, Moderna, Vaccine, coronavirus, pharma
Biotech firm Moderna has unveiled interim data from its Phase 1 trial of mRNA-1273, its vaccine against SARS-CoV-2, the virus …
AstraZeneca pledges to manufacture 30m units of Oxford University’s COVID-19 vaccine
May 19, 2020Manufacturing and Production AstraZeneca, COVID-19, UK, Vaccine, coronavirus, pharma
AstraZeneca has provided an update on the partnership it forged with the University of Oxford in late April to push …
US threatens to permanently cut off WHO funding
May 19, 2020Manufacturing and Production COVID-19, Trump, coronavirus
The US has threatened to permanently cut off funding to the World Health Organization if they do not take proposed …
Trump signs deal with generics company Phlow Corp to help shift drug manufacturing to the US
May 19, 2020Manufacturing and Production APIs, COVID-19, Drugs manufacturing, coronavirus, generics
The Trump administration will sign a $354 million deal with the generics company Phlow Corp to help produce medicines and …
Trump claims he is taking hydroxychloroquine to prevent contracting COVID-19
May 19, 2020Manufacturing and Production COVID-19, coronavirus, hydroxychloroquine
President Donald Trump told reporters last night that he is taking the drug hydroxychloroquine to ward off COVID-19, despite US …
Judge rejects Martin Shkreli’s prison release request to work on COVID-19 therapy
May 18, 2020Sales and Marketing COVID-19, Martin Shkreli, coronavirus
Notorious incarcerated ex-pharma CEO Martin Shkreli has his request rejected to be released from prison in order to research a …
New study on COVID-19 immune response shows promise for vaccine development
May 18, 2020Research and Development, Sales and Marketing COVID-19, coronavirus, pharma
Researchers at the labs of Dr Alessandro Sette and Dr Shane Crotty at California’s La Jolla Institute for Immunology have …
White House announces Dr Moncef Slaoui, the former head of GSK’s vaccine division, as the co-leader of Operation Warp Speed
May 18, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
President Donald Trump has announced that Dr Moncef Slaoui, the former head of GlaxoSmithKline’s vaccine division, will head up Operation …
Trump announces ‘Operation Warp Speed’ to develop a COVID-19 vaccine by the end of the year
May 18, 2020Sales and Marketing COVID-19, Trump, coronavirus
President Trump has announced a task force to quickly develop a vaccine for the US, titled Operation Warp Speed. Explaining …
Sanofi backtracks on promise of shipping COVID-19 vaccine to the US first
May 18, 2020Sales and Marketing COVID-19, coronavirus
Sanofi has backtracked on comments it made last week, where the company’s CEO said the US would get priority when …
Ex-BARDA chief warns of ‘darkest’ US winter in modern history due to COVID-19
May 18, 2020Sales and Marketing COVID-19, coronavirus
The former head of the Biomedical Advanced Research and Development Authority (BARDA) has warned that due to the US’s handling …
Genentech’s retiring R&D head to be replaced by MIT executive
May 15, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genentech, Roche, appointment
Michael Varney, industry veteran and Head of Research & Development at Genentech, has announced he is to leave the role …
Debra Feldman announced as Vice President, Head of Regulatory at Dyne Therapeutics
May 15, 2020Research and Development
Dyne Therapeutics has announced the appointment of Debra Feldman as their new Vice President, Head of Regulatory. Feldman said on …
Abbott’s COVID-19 test, used at the White House, fails to identify up to 48% of positive cases, study argues
May 15, 2020Medical Communications, Research and Development Abbott, COVID-19, coronavirus, pharma
Abbott’s 13-minute ID NOW COVID-19 testing kits have come under scrutiny after a study from New York University (NYU) revealed …
NIH will launch clinical trial testing hydroxychloroquine in combination with azithromycin as a COVID-19 treatment
May 15, 2020Medical Communications COVID-19, coronavirus
The US National Institutes of Health (NIH) said it is launching a clinical trial testing hydroxychloroquine in combination with azithromycin …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
